BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
What was lobbied
17 issue areas, each in the filer's own words, with who lobbied on it and where.
Agriculture AGR
Genetically Engineered (GE) Animals --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 -----Amendment on GE Salmon Labeling --One Health Legislation (Senate Discussion Draft) Review and Labeling of Food Derived From Biotechnology ---H.R. 1599: Safe and Accurate Food Labeling Act of 2015 ---U.S. Government Policy Funding for the USDA ---H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Foreign Agricultural Biotechnology Laws and Regulations ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations Potential Regulation of New Genetic Modification Technologies Funding for Biomass Crop Assistance Program ---H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Trade Promotion Authority ---HR 2146: Bipartisan Congressional Trade Priorities and Accountability Act of 2015 ---HR 1295: Trade Adjustment Assistance Act of 2015 Transatlantic Trade and Investment Partnership ---Ag-Biotech Issues Nutrition Policy ---Reauthorization of Federal School Nutrition Programs (Senate Discussion Draft)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH DAMOND | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| A. CATHARINE HARRIS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
Copyright/Patent/Trademark CPT
Patent Reform --H.R. 9: Innovation Act --Implementation of the America Invents Act of 2011 --S.1137: The PATENTS Act of 2015 Trans-Pacific Partnership --Data and Intellectual Property Protections for Pharmaceuticals Transatlantic Trade and Investment Partnership --Intellectual Property Issues Patenting of Biological Inventions --DNA Patenting and Licensing Trade Promotion Authority --HR 2146: Bipartisan Congressional Trade Priorities and Accountability Act of 2015 --HR 1295: Trade Adjustment Assistance Act of 2015 Inter Partes Review --H.R. 2578: Commerce, Science, Justice and Related Agencies Appropriations Act of FY 2016 --Implementation of the American Invents Act of 2011 --S. 1137: The PATENTS Act of 2015 --S. 632: STRONG Patents Act of 2011 --H.R. 9: Innovation Act Colombia National Development Plan --Intellectual Property Issues IP Rights for Environmental Technologies --U.S. Government Position for U.N. Convention on Climate Change Negotiations
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH DAMOND | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| CHARLES H FRITTS | — |
| JAMIE GREGORIAN | — |
| JEANNE HAGGERTY | — |
| A. CATHARINE HARRIS | — |
| SHELLY MUI-LIPNIK | — |
| HANSJORG SAUER | — |
| ANNA KATHERINE WEINSTEIN | — |
| DERRICK M WHITE | — |
Clean Air and Water (quality) CAW
IP Rights for Environmental Technologies --U.S. Government Position for U.N. Convention on Climate Change Negotiations
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH DAMOND | — |
| TOM DILENGE | — |
Consumer Issues/Safety/Products CSP
Genetically Engineered (GE) Animals --One Health Legislation (Senate Discussion Draft) --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 ----Amendment on GE Salmon Labeling Review and Labeling of Food Derived From Biotechnology --H.R. 1599: Safe and Accurate Food Labeling Act of 2015 --U.S. Government Policy Biosimilars --Implementation of Affordable Care Act --Interchangeability and Pharmacy Substitution --Naming --Reimbursement Policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| ANDREW EMMETT | — |
| JAMIE GREGORIAN | — |
| JEANNE HAGGERTY | — |
| A. CATHARINE HARRIS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
| JEFFREY PETERS | — |
| ANNA KATHERINE WEINSTEIN | — |
| DERRICK M WHITE | — |
Small Business SMB
Sarbanes Oxley Section 404 (b) --Public Company Accounting Oversight Board - Audit Cost Increases Capital Formation Investment Incentives --Reform of Capital Gains Rules --Reform of Net Operating Loss Rules --Reform of Passive Loss Rules --H.R. 2179: PARTNER Act --S. 341: Start-up Jobs and Innovation Act --S. 537: COMPETE Act Expansion of Exemption under SEC Regulation A --H.R. 1839: Reforming Access for Investments in Startup Enterprises (RAISE) Act Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions --Fostering Innovation Act (House Discussion Draft) XBRL Exemption for Small Public Companies --H.R. 1965: Small Company Disclosure Simplification Act --H.R. 37: Promoting Job Creation and Reducing Small Business Burdens Act Capital Market Enhancements --SEC Office of Small Business Policy Responsibilities --H.R. 1525: Disclosure Modernization and Simplification Act --H.R. 1675/S.576: Encouraging Employee Ownership Act --H.R. 1723: Small Company Simple Registration Act --H.R. 2064: Improving Access to Capital for Emerging Growth Companies Act --H.R. 2357: Accelerating Access to Capital Act Proxy Advisory Services --Impact of Policies on Small Public Companies
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES CRAIN | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| ELIZABETH CARTIER ESHAM | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| SHELLY MUI-LIPNIK | — |
Trade (domestic/foreign) TRD
Foreign Agricultural Biotechnology Laws and Regulations --China Biotechnology Regulations --EU Ag Biotech Policies and Regulations Colombia National Development Plan --Regulatory Issues --Intellectual Property Issues Trans-Pacific Partnership --Data and Intellectual Property Protections for Pharmaceuticals --Regulatory Transparency Transatlantic Trade and Investment Partnership --Ag-Biotech Issues --Regulatory Harmonization --Intellectual Property Issues --Reimbursement Transparency Trade Promotion Authority --H.R. 2146: Bipartisan Congressional Trade Priorities and Accountability Act of 2015 --H.R. 1295: Trade Adjustment Assistance Act of 2015 IP Rights for Environmental Technologies --U.S. Government Position for U.N. Convention on Climate Change Negotiations
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH DAMOND | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
| JEFFREY PETERS | — |
| DERRICK M WHITE | — |
Taxation/Internal Revenue Code TAX
Renewable Chemicals/Bio-based Products --New Production Tax Credit --Expansion of Master Limited Partnerships to Renewable Chemicals --H.R. 2833/S.1656: Master Limited Partnerships Parity Act of 2015 Biofuels --Production Tax Credit Extension Research & Development Tax Credit Reforms --Extension --Permanency --H.R.880: To amend the Internal Revenue Code to make permanent the credit for increasing research activities --S. 537: COMPETE Act Capital Formation Investment Incentives --Reform of Capital Gains Rules --Reform of Net Operating Loss Rules --Reform of Passive Loss Rules --S. 341: Start-up Jobs and Innovation Act --S. 537: COMPETE Act --H.R. 2179: PARTNER Act Tax Reform --Innovation/Patent Box Orphan Drug Act Tax Credit Inversions --H.R. 2995: Department of Financial Services and Related Agencies Appropriations Act for FY 2016
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES CRAIN | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| ELIZABETH CARTIER ESHAM | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| ERICK LUTT | — |
| SHELLY MUI-LIPNIK | — |
| DANA MAURICE O'BRIEN | — |
| RINA SINGH | — |
| DERRICK M WHITE | — |
Health Issues HCR
Biosimilars --Naming --Interchangeability and Pharmacy Substitution --Implementation of Affordable Care Act --Patent Certification --Reimbursement Policy Funding for National Institutes of Health --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for Centers for Disease Control and Prevention Vaccine Programs --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 340B Drug Pricing Program --Program Implementation & Oversight --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Medicaid Pricing and Rebates --Average Manufacturer Price Calculations --Implementation of Affordable Care Act Funding for FDA --H.R. 3049/S. 1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Biodefense Research, Development, and Procurement Issues Reimbursement for Innovative Products --Medicare Part D Prescription Drug Program --Medicare Part B Physician-Administered Products Sequestration of PDUFA Fees --HR 1078: Food and Drug Administration Safety over Sequestration Act of 2015 --Implementation of S. 365: Budget Control Act --S. 1413: FDA User Fee Protection Act Drug Evaluation and Review --Implementation of the FDA Safety and Innovation Act/Prescription Drug User Fee Act Orphan Drug Act Tax Credit 21st Century Cures Initiative --Biomarkers and Regulatory Science Improvements --Communication with Healthcare Professionals and Payers --Expanded Access to Investigational Drugs --Expedited Pathways --FDA Hiring Flexibility --FDA Management and Financial Accountability --Innovation Incentives --Longitudinal Study of Chronic Diseases --Patient Access to Approved Drugs --Patient-Focused Drug Development --Use of Real-World Evidence --Vaccine and Anti-Microbial Resistance Product Development and Incentives --ADAPT Act (House Discussion Draft) --DISARM Act (House Discussion Draft) --Medicare Part D Low-Income Subsidy Increased Co-Pay --Biosimilars Reimbursement Policy --Authorized Generics Reimbursement Calculation --Reimbursement for Infusion Drugs under Medicare Part B Colombia National Development Plan --Regulatory Issues --Intellectual Property Issues Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Combating Antibiotic-Resistant Bacteria (CARB) Initiative --ADAPT Act (House Discussion Draft) --DISARM Act (House Discussion Draft) Trans-Pacific Partnership --Data and Intellectual Property Protections for Pharmaceuticals --Regulatory Transparency Transatlantic Trade and Investment Partnership --Regulatory Harmonization --Intellectual Property Issues --Reimbursement Transparency Medicare Physician Payment Sustainable Growth Rate Formula --H.R. 2: Medicare Access and CHIP Reauthorization Act of 2015
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| ANDREW EMMETT | — |
| ELIZABETH CARTIER ESHAM | — |
| CHARLES H FRITTS | — |
| JAMIE GREGORIAN | — |
| JEANNE HAGGERTY | — |
| A. CATHARINE HARRIS | — |
| ERIN ESTEY HERTZOG New | — |
| KATHLEEN HOLCOMBE | — |
| TRACEY LATURNER | — |
| SHELLY MUI-LIPNIK | — |
| JEFFREY PETERS | — |
| AMY WALKER | — |
| ANNA KATHERINE WEINSTEIN | — |
| DERRICK M WHITE | — |
Medicare/Medicaid MMM
Medicaid Pricing and Rebates --Average Manufacturer Price Calculations --Implementation of Affordable Care Act Reimbursement for Innovative Products --Medicare Part D Prescription Drug Program --Medicare Part B Physician-Administered Products Medicare Physician Payment Sustainable Growth Rate Formula --H.R. 2: Medicare Access and CHIP Reauthorization Act of 2015 21st Century Cures Initiative --Patient Access to Approved Drugs --Medicare Part D Low-Income Subsidy Increased Co-Pay --Biosimilars Reimbursement Policy --Authorized Generics Reimbursement Calculations --Reimbursement for Infusion Drugs under Medicare Part B
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| ELIZABETH CARTIER ESHAM | — |
| JAMIE GREGORIAN | — |
| JEANNE HAGGERTY | — |
| A. CATHARINE HARRIS | — |
| ERIN ESTEY HERTZOG New | — |
| KATHLEEN HOLCOMBE | — |
| JEFFREY PETERS | — |
| ANNA KATHERINE WEINSTEIN | — |
| DERRICK M WHITE | — |
Budget/Appropriations BUD
Funding for the USDA --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for FDA --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for Centers for Disease Control and Prevention Vaccine Programs --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for National Institutes of Health --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for Biomass Crop Assistance Program --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Sequestration of PDUFA Fees --HR 2725: Food and Drug Administration Safety over Sequestration Act of 2015 --Implementation of S. 365: Budget Control Act --S. 1413: FDA User Fee Protection Act Funding for Renewable Chemicals/Bio-based Products --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for Biofuels --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 --Department of Defense Funding of Advanced Biofuels --H.R. 2685/S.1558: Department of Defense Appropriations Act for FY 2016 --H.R.2028: Energy and Water Development and Related Agencies Appropriations Act for FY 2016, --H.R.2822: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2016 Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| BRENT ALAN DELMONTE | — |
| ANDREW EMMETT | — |
| JEANNE HAGGERTY | — |
| A. CATHARINE HARRIS | — |
| TRACEY LATURNER | — |
| ERICK LUTT | — |
| RINA SINGH | — |
| AMY WALKER | — |
| ANNA KATHERINE WEINSTEIN | — |
| DERRICK M WHITE | — |
Chemicals/Chemical Industry CHM
Renewable Chemicals/Bio-based Products (Non-Funding) --Expansion of Master Limited Partnerships to Renewable Chemicals --H.R. 2833/S.1656: Master Limited Partnerships Parity Act of 2015 --Investment Tax Credit for Renewable Chemicals and Bio-based Products --New Production Tax Credit --S. 1447: Sustainable Chemistry Research and Development Act --S. 697: Chemical Safety for the 21st Century Act Funding for Renewable Chemicals/Bio-based Products and Biorefineries --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 --Implementation of the Agricultural Act of 2014, Energy Title IX, Section 9003
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| ERICK LUTT | — |
| DANA MAURICE O'BRIEN | — |
| RINA SINGH | — |
Energy/Nuclear ENG
Biofuels (Non-Funding) --Implementation of the Agricultural Act of 2014 --Production Tax Credit Extension --Renewable Fuel Standard Funding for Biomass Crop Assistance Program --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for Renewable Chemicals/Bio-based Products and Biorefineries --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 --Implementation of the Agricultural Act of 2014, Energy Title IX, Section 9003 Funding for Biofuels --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 --Department of Defense Funding of Advanced Biofuels --H.R. 2685/S.1558: Department of Defense Appropriations Act for FY 2016, --H.R. 2028: Energy and Water Development and Related Agencies Appropriations Act for FY 2016 --H.R.2822: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2016 --Implementation of the Agricultural Act of 2014
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| ERICK LUTT | — |
| DANA MAURICE O'BRIEN | — |
| RINA SINGH | — |
Food Industry (safety, labeling, etc.) FOO
Genetically Engineered (GE) Animals --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 ----Amendment on GE Salmon Labeling --One Health Legislation (Senate Discussion Draft) Review and Labeling of Food Derived From Biotechnology --H.R. 1599: Safe and Accurate Food Labeling Act of 2015 --U.S. Government Policy Nutrition Policy --Reauthorization of Federal School Nutrition Programs (Senate Discussion Draft)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TOM DILENGE | — |
| JEANNE HAGGERTY | — |
| A. CATHARINE HARRIS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
Animals ANI
Genetically Engineered (GE) Animals --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 ----Amendment on GE Salmon Labeling --One Health Legislation (Senate Discussion Draft)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DELMONTE | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
Fuel/Gas/Oil FUE
Biofuels (Non-Funding) --Implementation of the Agricultural Act of 2014 --Production Tax Credit Extension --Renewable Fuel Standard Funding for Biomass Crop Assistance Program --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for Renewable Chemicals/Bio-based Products and Biorefineries --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 --Implementation of the Agricultural Act of 2014, Energy Title IX, Section 9003 Funding for Biofuels --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 --Department of Defense Funding of Advanced Biofuels --H.R. 2685/S.1558: Department of Defense Appropriations Act for FY 2016, --H.R.2028: Energy and Water Development and Related Agencies Appropriations Act for FY 2016 --H.R.2822: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2016 --Implementation of the Agricultural Act of 2014
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| ERICK LUTT | — |
| DANA MAURICE O'BRIEN | — |
| RINA SINGH | — |
Homeland Security HOM
Biodefense Research, Development, and Procurement Issues (Non-funding) Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Combating Antibiotic-Resistant Bacteria (CARB) Initiative --ADAPT Act (House Discussion Draft) --DISARM Act (House Discussion Draft)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| ELIZABETH CARTIER ESHAM | — |
| JEANNE HAGGERTY | — |
| KATHLEEN HOLCOMBE | — |
| TRACEY LATURNER | — |
| JEFFREY PETERS | — |
| AMY WALKER | — |
Medical/Disease Research/Clinical Labs MED
Funding for National Institutes of Health --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 21st Century Cures Initiative --Longitudinal Study of Chronic Diseases Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Combating Antibiotic-Resistant Bacteria (CARB) Initiative --ADAPT Act (House Discussion Draft) --DISARM Act (House Discussion Draft)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| ANDREW EMMETT | — |
| ELIZABETH CARTIER ESHAM | — |
| JAMIE GREGORIAN | — |
| JEANNE HAGGERTY | — |
| A. CATHARINE HARRIS | — |
| ERIN ESTEY HERTZOG New | — |
| KATHLEEN HOLCOMBE | — |
| TRACEY LATURNER | — |
| JEFFREY PETERS | — |
| AMY WALKER | — |
| ANNA KATHERINE WEINSTEIN | — |
| DERRICK M WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.